ES2703530T3 - Composición cicatrizante y utilización - Google Patents

Composición cicatrizante y utilización Download PDF

Info

Publication number: ES2703530T3
Authority: ES; Spain
Prior art keywords: composition; honey; treatment; use according; hyaluronic acid
Prior art date: 2013-06-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES14731686T

Other languages

English (en)

Spanish (es)

Inventor

Fabien Quero

Carmen Malepeyre

Anaïs Raynaud

Jean-Michel Petit

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MELIPHARM

Original Assignee

MELIPHARM

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-06-20

Filing date

2014-05-14

Publication date

2019-03-11

2014-05-14 Application filed by MELIPHARM filed Critical MELIPHARM

2019-03-11 Application granted granted Critical

2019-03-11 Publication of ES2703530T3 publication Critical patent/ES2703530T3/es

Status Active legal-status Critical Current

2034-05-14 Anticipated expiration legal-status Critical

Links

239000000203 mixture Substances 0.000 title claims abstract description 145
230000035876 healing Effects 0.000 title claims abstract description 25
235000012907 honey Nutrition 0.000 claims abstract description 95
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 42
229920002674 hyaluronan Polymers 0.000 claims abstract description 42
229960003160 hyaluronic acid Drugs 0.000 claims abstract description 42
102000008186 Collagen Human genes 0.000 claims abstract description 35
108010035532 Collagen Proteins 0.000 claims abstract description 35
229920001436 collagen Polymers 0.000 claims abstract description 35
229920002498 Beta-glucan Polymers 0.000 claims abstract description 31
FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 19
230000000844 anti-bacterial effect Effects 0.000 claims abstract description 19
102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 14
108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 14
210000002744 extracellular matrix Anatomy 0.000 claims abstract description 14
239000000470 constituent Substances 0.000 claims abstract description 12
102000016942 Elastin Human genes 0.000 claims abstract description 11
108010014258 Elastin Proteins 0.000 claims abstract description 11
229920002549 elastin Polymers 0.000 claims abstract description 11
229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 10
239000007788 liquid Substances 0.000 claims abstract description 7
230000000699 topical effect Effects 0.000 claims abstract description 6
230000036541 health Effects 0.000 claims abstract description 5
208000027418 Wounds and injury Diseases 0.000 claims description 24
206010052428 Wound Diseases 0.000 claims description 22
235000007303 Thymus vulgaris Nutrition 0.000 claims description 12
239000001585 thymus vulgaris Substances 0.000 claims description 12
239000006071 cream Substances 0.000 claims description 9
239000000499 gel Substances 0.000 claims description 9
235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 7
230000002265 prevention Effects 0.000 claims description 7
240000003553 Leptospermum scoparium Species 0.000 claims description 6
235000016887 Leptospermum scoparium Nutrition 0.000 claims description 6
239000002674 ointment Substances 0.000 claims description 6
230000002980 postoperative effect Effects 0.000 claims description 4
239000007921 spray Substances 0.000 claims description 4
229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
229920002971 Heparan sulfate Polymers 0.000 claims description 3
229940107200 chondroitin sulfates Drugs 0.000 claims description 3
230000001684 chronic effect Effects 0.000 claims description 3
231100000241 scar Toxicity 0.000 claims description 3
150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 3
208000002874 Acne Vulgaris Diseases 0.000 claims description 2
206010006797 Burns first degree Diseases 0.000 claims description 2
206010006802 Burns second degree Diseases 0.000 claims description 2
208000010445 Chilblains Diseases 0.000 claims description 2
206010008528 Chillblains Diseases 0.000 claims description 2
201000004624 Dermatitis Diseases 0.000 claims description 2
206010015150 Erythema Diseases 0.000 claims description 2
229930091371 Fructose Natural products 0.000 claims description 2
239000005715 Fructose Substances 0.000 claims description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
206010017533 Fungal infection Diseases 0.000 claims description 2
206010021531 Impetigo Diseases 0.000 claims description 2
206010028116 Mucosal inflammation Diseases 0.000 claims description 2
201000010927 Mucositis Diseases 0.000 claims description 2
206010034016 Paronychia Diseases 0.000 claims description 2
208000000528 Pilonidal Sinus Diseases 0.000 claims description 2
206010035043 Pilonidal cyst Diseases 0.000 claims description 2
206010039580 Scar Diseases 0.000 claims description 2
229930006000 Sucrose Natural products 0.000 claims description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
208000025865 Ulcer Diseases 0.000 claims description 2
206010000496 acne Diseases 0.000 claims description 2
230000001154 acute effect Effects 0.000 claims description 2
208000002399 aphthous stomatitis Diseases 0.000 claims description 2
210000001217 buttock Anatomy 0.000 claims description 2
239000000839 emulsion Substances 0.000 claims description 2
231100000321 erythema Toxicity 0.000 claims description 2
208000024386 fungal infectious disease Diseases 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
239000007934 lip balm Substances 0.000 claims description 2
210000002445 nipple Anatomy 0.000 claims description 2
229940041672 oral gel Drugs 0.000 claims description 2
229940100681 rectal cream Drugs 0.000 claims description 2
230000008439 repair process Effects 0.000 claims description 2
239000005720 sucrose Substances 0.000 claims description 2
230000000472 traumatic effect Effects 0.000 claims description 2
231100000397 ulcer Toxicity 0.000 claims description 2
229940044950 vaginal gel Drugs 0.000 claims description 2
239000000029 vaginal gel Substances 0.000 claims description 2
235000007173 Abies balsamea Nutrition 0.000 claims 1
239000004857 Balsam Substances 0.000 claims 1
206010051814 Eschar Diseases 0.000 claims 1
240000008620 Fagopyrum esculentum Species 0.000 claims 1
244000018716 Impatiens biflora Species 0.000 claims 1
240000002657 Thymus vulgaris Species 0.000 claims 1
231100000333 eschar Toxicity 0.000 claims 1
229940120293 vaginal suppository Drugs 0.000 claims 1
239000006216 vaginal suppository Substances 0.000 claims 1
239000000047 product Substances 0.000 description 27
230000035755 proliferation Effects 0.000 description 27
210000002950 fibroblast Anatomy 0.000 description 19
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
210000004027 cell Anatomy 0.000 description 18
230000000694 effects Effects 0.000 description 13
229920002385 Sodium hyaluronate Polymers 0.000 description 12
150000001875 compounds Chemical class 0.000 description 12
210000002510 keratinocyte Anatomy 0.000 description 12
229940010747 sodium hyaluronate Drugs 0.000 description 12
239000000243 solution Substances 0.000 description 12
230000002195 synergetic effect Effects 0.000 description 12
241000246358 Thymus Species 0.000 description 11
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 11
230000001580 bacterial effect Effects 0.000 description 10
238000011156 evaluation Methods 0.000 description 9
238000012360 testing method Methods 0.000 description 8
239000000843 powder Substances 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
241000219051 Fagopyrum Species 0.000 description 6
239000001963 growth medium Substances 0.000 description 6
238000002156 mixing Methods 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000000034 method Methods 0.000 description 4
210000004400 mucous membrane Anatomy 0.000 description 4
239000000546 pharmaceutical excipient Substances 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
235000010384 tocopherol Nutrition 0.000 description 4
229960001295 tocopherol Drugs 0.000 description 4
229930003799 tocopherol Natural products 0.000 description 4
239000011732 tocopherol Substances 0.000 description 4
229940042585 tocopherol acetate Drugs 0.000 description 4
239000001993 wax Substances 0.000 description 4
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
239000002250 absorbent Substances 0.000 description 3
239000000654 additive Substances 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000000975 dye Substances 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
230000005855 radiation Effects 0.000 description 3
-1 shortening Substances 0.000 description 3
229910052709 silver Inorganic materials 0.000 description 3
239000004332 silver Substances 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
239000000829 suppository Substances 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
230000029663 wound healing Effects 0.000 description 3
241000251468 Actinopterygii Species 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
241000282412 Homo Species 0.000 description 2
QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
241001135917 Vitellaria paradoxa Species 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
230000002745 absorbent Effects 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
235000010385 ascorbyl palmitate Nutrition 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000003592 biomimetic effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
229910002091 carbon monoxide Inorganic materials 0.000 description 2
238000001816 cooling Methods 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
231100000433 cytotoxic Toxicity 0.000 description 2
230000001472 cytotoxic effect Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
230000003328 fibroblastic effect Effects 0.000 description 2
239000003349 gelling agent Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
125000005456 glyceride group Chemical group 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
208000014674 injury Diseases 0.000 description 2
239000006210 lotion Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000002609 medium Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
229940057910 shea butter Drugs 0.000 description 2
206010040882 skin lesion Diseases 0.000 description 2
231100000444 skin lesion Toxicity 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
244000144927 Aloe barbadensis Species 0.000 description 1
235000002961 Aloe barbadensis Nutrition 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
206010012442 Dermatitis contact Diseases 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
206010016936 Folliculitis Diseases 0.000 description 1
206010017553 Furuncle Diseases 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
102000010445 Lactoferrin Human genes 0.000 description 1
108010063045 Lactoferrin Proteins 0.000 description 1
108010023244 Lactoperoxidase Proteins 0.000 description 1
102000045576 Lactoperoxidases Human genes 0.000 description 1
244000062730 Melissa officinalis Species 0.000 description 1
235000010654 Melissa officinalis Nutrition 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
208000004210 Pressure Ulcer Diseases 0.000 description 1
241000241413 Propolis Species 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
208000028990 Skin injury Diseases 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229960000458 allantoin Drugs 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
235000011399 aloe vera Nutrition 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
229940092782 bentonite Drugs 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000000648 calcium alginate Substances 0.000 description 1
235000010410 calcium alginate Nutrition 0.000 description 1
229960002681 calcium alginate Drugs 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000007765 cera alba Substances 0.000 description 1
229940106189 ceramide Drugs 0.000 description 1
150000001783 ceramides Chemical class 0.000 description 1
229940081733 cetearyl alcohol Drugs 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000008139 complexing agent Substances 0.000 description 1
208000010247 contact dermatitis Diseases 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
230000001815 facial effect Effects 0.000 description 1
150000002194 fatty esters Chemical class 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
229930182478 glucoside Natural products 0.000 description 1
150000008131 glucosides Chemical class 0.000 description 1
229940075529 glyceryl stearate Drugs 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
239000000416 hydrocolloid Substances 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
229940099563 lactobionic acid Drugs 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
229940057428 lactoperoxidase Drugs 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
239000006994 mh medium Substances 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000005416 organic matter Substances 0.000 description 1
229940101267 panthenol Drugs 0.000 description 1
239000011619 pantothenol Substances 0.000 description 1
235000020957 pantothenol Nutrition 0.000 description 1
239000001814 pectin Substances 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
AMCPECLBZPXAPB-UHFFFAOYSA-N propane-1,2,3-triol;sodium Chemical compound [Na].OCC(O)CO AMCPECLBZPXAPB-UHFFFAOYSA-N 0.000 description 1
229940069949 propolis Drugs 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
229940041666 rectal gel Drugs 0.000 description 1
229940100618 rectal suppository Drugs 0.000 description 1
238000011160 research Methods 0.000 description 1
239000006254 rheological additive Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
238000004904 shortening Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
230000008591 skin barrier function Effects 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
229940031439 squalene Drugs 0.000 description 1
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
150000003567 thiocyanates Chemical class 0.000 description 1
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
238000005292 vacuum distillation Methods 0.000 description 1
MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
235000012141 vanillin Nutrition 0.000 description 1
229940117960 vanillin Drugs 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1
239000011787 zinc oxide Substances 0.000 description 1
229960001296 zinc oxide Drugs 0.000 description 1
235000014692 zinc oxide Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Insects & Arthropods (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Animal Husbandry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

ES14731686T 2013-06-20 2014-05-14 Composición cicatrizante y utilización Active ES2703530T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1355810A FR3007291B1 (fr)	2013-06-20	2013-06-20	Composition cicatrisante et utlisation
PCT/FR2014/051123 WO2014202851A1 (fr)	2013-06-20	2014-05-14	Composition cicatrisante et utilisation

Publications (1)

Publication Number	Publication Date
ES2703530T3 true ES2703530T3 (es)	2019-03-11

Family

ID=48980160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES14731686T Active ES2703530T3 (es)	2013-06-20	2014-05-14	Composición cicatrizante y utilización

Country Status (5)

Country	Link
US (1)	US20160367605A1 (fr)
EP (1)	EP3010516B1 (fr)
ES (1)	ES2703530T3 (fr)
FR (1)	FR3007291B1 (fr)
WO (1)	WO2014202851A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITUB20155902A1 (it)	2015-11-25	2017-05-25	Nathura S P A	Composizione farmaceutica cicatrizzante per uso topico
WO2017151835A1 (fr) *	2016-03-03	2017-09-08	Access Business Group International Llc	Composition pour inhiber la déshydratation de la peau comportant un humectant et du miel
EP3852872B1 (fr) *	2018-09-18	2023-08-23	Fadim Ltd	Composition pour le traitement de la cavité buccale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1258722A (fr)	1960-06-03	1961-04-14	Boehler & Co Ag Geb	Appareil de forage par choc
US6541460B2 (en) *	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
US6630442B1 (en) *	1997-01-10	2003-10-07	Theodore Hersh	Reparatives for chemosurgery and laser (thermal) therapy
CH699182B1 (fr) *	2008-07-17	2012-03-15	Care Cosmeceuticals Sarl	Mélanges de miel d'abeilles pour le traitement dermatologique des plaies chroniques.
US20110104279A1 (en) *	2009-11-04	2011-05-05	Marraccini Philip A	Healing powder and method of use thereof

2013
- 2013-06-20 FR FR1355810A patent/FR3007291B1/fr not_active Expired - Fee Related
2014
- 2014-05-14 US US14/900,504 patent/US20160367605A1/en not_active Abandoned
- 2014-05-14 WO PCT/FR2014/051123 patent/WO2014202851A1/fr not_active Ceased
- 2014-05-14 ES ES14731686T patent/ES2703530T3/es active Active
- 2014-05-14 EP EP14731686.3A patent/EP3010516B1/fr active Active

Also Published As

Publication number	Publication date
US20160367605A1 (en)	2016-12-22
FR3007291A1 (fr)	2014-12-26
WO2014202851A1 (fr)	2014-12-24
FR3007291B1 (fr)	2015-07-17
EP3010516A1 (fr)	2016-04-27
EP3010516B1 (fr)	2018-09-26

Publication	Publication Date	Title
CN105012993B (zh)	2018-03-23	一种阳离子医用生物胶抗菌敷料及其制备方法
ES2560953T3 (es)	2016-02-23	Extractos de plantas combinados para usar en el tratamiento de infecciones microbianas
BRPI0709501A2 (pt)	2011-07-19	composição ternária, composição curativa do ferimento processo para a preparação de uma composição ternária , composição cosmética, uso de uma mistura ternária da argila , mel e óleo curativos e medicamentos
CO6650416A2 (es)	2013-04-15	Una composición farmacéutica sinergística novedosa para aplicaciones tópicas
RU2668827C2 (ru)	2018-10-02	Топическая противомикробная дерматологическая композиция
RU2014137827A (ru)	2016-05-20	Композиции и применение противомикробных материалов со свойствами биологической совместимости
ES2719847T3 (es)	2019-07-16	Composición antiséptica
EA014391B1 (ru)	2010-10-29	Фармацевтическая композиция для лечения ожогов и способ ее получения
US20170072024A1 (en)	2017-03-16	Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide
US9757328B2 (en)	2017-09-12	Lysozyme gel formulations
ES2335555T3 (es)	2010-03-29	Uso de polietilenglicol en trastornos o enfermedades topicas relacionadas con la inflamacion y en cicatrizacion de heridas.
ES2703530T3 (es)	2019-03-11	Composición cicatrizante y utilización
Adikwu et al.	2007	Application of snail mucin dispersed in detarium gum gel in wound healing
ES2588397T3 (es)	2016-11-02	Composiciones con actividad antibacteriana y de curación de heridas
RU2470640C1 (ru)	2012-12-27	Средство для лечения воспалительных заболеваний полости рта и способ лечения воспалительных заболеваний полости рта
EP2755670B1 (fr)	2016-05-11	Compositions utilisables en vue du traitement d'ulcères périphériques d'origine variée
RU2636530C2 (ru)	2017-11-23	Фармацевтическая композиция для лечения ран и ожогов
ES2392436T3 (es)	2012-12-10	Composiciones farmacéuticas para el tratamiento de ulceraciones crónicas
RU2601897C1 (ru)	2016-11-10	Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
ES2971823T3 (es)	2024-06-07	Mejora de las acciones antibacterianas de un antibiótico depsipeptídico mediante cantidades sinérgicas de ácido bórico
RU2521209C1 (ru)	2014-06-27	Водорастворимая бактерицидная репаративная композиция
ES2629930T3 (es)	2017-08-16	Composición dermoprotectora y dermoequilibrante
RU2675246C1 (ru)	2018-12-18	Мазь ожогозаживляющего действия
RU2682454C1 (ru)	2019-03-20	Мазь для лечения термических ожогов и способ их лечения
IT202000003934A1 (it)	2021-08-26	Formulazione a base naturale per l’uso nel trattamento di disturbi proctologici